Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Phio Pharmaceuticals Corp. Director's Dealing 2024

Aug 9, 2024

35112_dirs_2024-08-09_93266756-5e4c-49fb-ad0f-ba5fc0f61ceb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phio Pharmaceuticals Corp. (PHIO)
CIK: 0001533040
Period of Report: 2024-08-01

Reporting Person: Infarinato Robert M. (VP, Chief Financial Officer)

More from Phio Pharmaceuticals Corp.

Regulatory Filings 2026
Apr 8
Regulatory Filings 2026
Mar 30
Regulatory Filings 2026
Feb 23
Regulatory Filings 2026
Feb 18
Major Shareholding Notification 2026
Feb 17
Regulatory Filings 2026
Feb 10
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
View all filings →